2018 Oklahoma Geroscience Meeting
Oklahoma City, Oklahoma | April 6, 2018
The Role of the IGF1/Insulin
Signaling Pathway in Aging and Diabetes
Keynote Speaker, Nir Barzilai, MD
Professor of Medicine and Director Institute for Aging Research
Albert Einstein College of Medicine
Session 1. Insulin/IGF1 Signaling and Contributions to Lifespan Regulation
Arlan Richardson, Ph.D., Director of the Oklahoma Nathan Shock Aging
Center
Introduction/Welcome
Marc Tatar, Ph.D., Professor of Ecology and Evolutionary Biology, Brown
University
Mechanisms of aging regulation by insulin/IGF
signaling in Drosophila
Andrzej Bartke, Ph.D., Professor of Physiology, Southern Illinois University School of Medicine
Role of insulin sensitivity in aging
Yousin Suh, Ph.D., Professor Department of Genetics, Einstein College of
Medicine
IGF1 receptor signaling in human centenarians
Session 2. Effects of Insulin and IGF1 on Brain Function
William E. Sonntag, Ph.D., Professor of Geriatric Medicine and
Director of Reynolds Oklahoma Center on Aging, OUHSC
The effect of reduced IGF1 expression on healthspan and longevity
of mice
William Banks, M.D., Professor of Internal Medicine, University of
Washington
Effect of insulin on brain functions
Session 3. Insulin/IGF1 Resistance and Aging
Jian-xing Ma, M.D./Ph.D., Professor and Chair of Physiology
New insights into the role of insulin signaling in age-related retinal
degeneration
Pinchas Cohen, M.D., Dean Davis School of Gerontology, University of Southern California
Role of mitochondrial-derived peptides in insulin resistance and aging
Nick Musi, M.D., Professor of Medicine and Director of the Barshop Institute on Longevity and Aging Studies, University of Texas
Health Science Center at San Antonio
How aging contributes to insulin resistance and diabetes